(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-1.16% TWD 93.80
Live Chart Being Loaded With Signals
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis...
Stats | |
---|---|
Volumen de hoy | 248 609 |
Volumen promedio | 1.06M |
Capitalización de mercado | 13.47B |
EPS | TWD0 ( 2024-04-26 ) |
Próxima fecha de ganancias | ( TWD0.550 ) 2024-07-24 |
Last Dividend | TWD0 ( N/A ) |
Next Dividend | TWD0 ( N/A ) |
P/E | 49.11 |
ATR14 | TWD0.0430 (0.05%) |
Volumen Correlación
PharmaEngine, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PharmaEngine, Inc. Correlación - Moneda/Commodity
PharmaEngine, Inc. Finanzas
Annual | 2023 |
Ingresos: | TWD767.67M |
Beneficio Bruto: | TWD718.97M (93.66 %) |
EPS: | TWD1.910 |
FY | 2023 |
Ingresos: | TWD767.67M |
Beneficio Bruto: | TWD718.97M (93.66 %) |
EPS: | TWD1.910 |
FY | 2022 |
Ingresos: | TWD654.38M |
Beneficio Bruto: | TWD604.68M (92.41 %) |
EPS: | TWD2.22 |
FY | 2021 |
Ingresos: | TWD654.84M |
Beneficio Bruto: | TWD617.76M (94.34 %) |
EPS: | TWD2.93 |
Financial Reports:
No articles found.
PharmaEngine, Inc.
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico